Axogen, Inc Reports 2022 Third Quarter Financial Results
ALACHUA, Fla. and TAMPA, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the third quarter ended September 30, 2022.
Related news for (AXGN)
- Axogen Announces Chief Financial Officer Transition
- Axogen, Inc. Reports 2025 First Quarter Financial Results
- Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
- Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
- axogen completes submission of biologics license application to u.s. food and drug administration for avance nerve graft®